劲方医药-B今日盘中股价大幅下跌11.85%，引发了市场关注。
消息面上，劲方医药（上海）股份有限公司发布声明，澄清Revmed往来函件中提及的所有实体、产品或争议事项均与本公司完全无关。市场分析认为，股价的剧烈波动可能与此前市场对公司可能卷入相关争议的担忧有关，公司的澄清声明旨在消除误解。
劲方医药-B今日盘中股价大幅下跌11.85%，引发了市场关注。
消息面上，劲方医药（上海）股份有限公司发布声明，澄清Revmed往来函件中提及的所有实体、产品或争议事项均与本公司完全无关。市场分析认为，股价的剧烈波动可能与此前市场对公司可能卷入相关争议的担忧有关，公司的澄清声明旨在消除误解。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.